Breast cancer can be divided into 4 subtypes (luminal A, luminal B, HER2, and triple negative breast cancer), following the indications of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.